{
  "trial_id": "NCT00162812",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically-confirmed breast cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age less than 70 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Female patient",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Tumor size 2 cm at ultrasound examination.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ER-negative tumors defined according to immunohistochemistry (i.e. < 10% of positive cells after immunostaining).",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Multifocal and multicentric breast tumors are allowed if all foci are ER-negative.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Fixed and frozen samples from the primary tumor, obtained before treatment with epirubicin, must be available for evaluation of biological markers (topo II alpha gene and protein, HER-2 gene, p-53 gene, oligonucleotides microarrays).",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Written informed consent before study registration.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Performance status 0 or 1 (ECOG scale)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Normal CBC, hepatic and renal functions",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Normal left ventricular ejection fraction by echocardiography or muga scan",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Negative pregnancy test for all women of childbearing potential. Patients of childbearing potential must implement adequate non-hormonal measures to avoid pregnancy during treatment.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Metastatic breast cancer",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Serious medical conditions like: congestive heart failure or unstable angina pectoris, previous history of myocardial infarction within 1 year from study entry, uncontrolled arrhythmias.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "history of significant neurologic or psychiatric disorders",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "active uncontrolled infection",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "active peptic ulcer, unstable diabetes mellitus",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Concomitant contralateral invasive breast cancer",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Concurrent treatment with hormonal replacement therapy",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Concurrent treatment with any other anti-cancer therapy",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has Turner syndrome, short stature, delayed puberty and developmental delay. She is obese and mentally retarded.",
  "_meta": {
    "topic_id": "49",
    "trial_id": "NCT00162812",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}